Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Phio Pharmaceuticals Corp (PHIO)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 5,780,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.3302 - $0.3302
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year    
 
Company Profile   Phio Pharmaceuticals is developing therapeutics that use its INTASYL™ technology to target both tumor and immune cells by regulating genes to strengthen a patient's immune system while weakening tumor defense mechanisms. Co.'s INTASYL-based therapeutics are used to: strengthen immune cells, for example those administered as part of adoptive cell therapy (ACT), and directly modify cells in the tumor microenvironment to weaken a tumor's defense. Co.'s lead product candidate being developed by Co. in ACT is PH-762. Co.'s second product candidate in development for use in ACT is PH-894. Co.'s INTASYL compound PH-804 is also being developed for use in ACT.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 2,500 2,500 6,500 22,216
Total Buy Value $2,275 $2,275 $14,195 $22,362
Total People Bought 1 1 2 2
Total Buy Transactions 1 1 4 12
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-18 2023-11-17 2023-05-19 2022-05-19

   
Records found: 134
  Page 5 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Cauwenbergh Geert President & CEO   •       •      –    2017-02-17 4 B $0.69 $6,931 D/D 10,000 92,583 2.81     -
   Cauwenbergh Geert President & CEO   •       •      –    2017-02-08 4 B $0.69 $6,850 D/D 10,000 82,583 2.81     -
   Cauwenbergh Geert President & CEO   •       •      –    2017-01-25 4 B $0.69 $6,966 D/D 10,000 72,583 2.81     -
   Cauwenbergh Geert President & CEO   •       •      –    2017-01-19 4 B $0.69 $6,949 D/D 10,000 62,583 2.81     -
   Cauwenbergh Geert President & CEO   •       •      –    2016-12-30 4 A $0.73 $1,452 D/D 2,000 52,583     -
   Cauwenbergh Geert President & CEO   •       •      –    2016-12-23 4 A $0.72 $2,157 I/I 3,000 4,500     -
   Cauwenbergh Geert President & CEO   •       •      –    2016-12-22 4 A $0.75 $2,247 D/D 3,000 53,583     -
   Cauwenbergh Geert President & CEO   •       •      –    2016-12-16 4 A $0.90 $30,000 D/D 33,333 50,583     -
   Pavco Pamela Chief Development Officer   •       –      –    2016-12-16 4 A $0.90 $10,000 D/D 11,111 17,173     -
   Cauwenbergh Geert President & CEO   •       •      –    2015-06-22 4 OE $0.46 $15,925 D/D 35,000 172,500     -
   Pavco Pamela Chief Development Officer   •       –      –    2015-06-02 4 A $0.40 $5,000 D/D 12,500 33,718     -
   Dorman H. Paul Director   –       •      –    2015-06-02 4 A $0.40 $15,000 D/D 37,500 37,500     -
   Cauwenbergh Geert President & CEO   •       •      –    2015-06-02 4 A $0.40 $4,000 I/I 10,000 15,000     -
   Cauwenbergh Geert President & CEO   •       •      –    2015-06-02 4 A $0.40 $28,000 D/D 70,000 137,500     -
   Lockshin Curtis Director   –       •      –    2015-06-02 4 A $0.40 $4,800 D/D 12,000 13,000     -
   Bitterman Robert J Director   –       •      –    2015-06-02 4 A $0.40 $15,000 D/D 37,500 44,000     -
   Cauwenbergh Geert President & CEO   •       •      –    2015-04-02 4 B $0.72 $3,596 D/D 5,000 67,500 2.73     -
   Cauwenbergh Geert President & CEO   •       •      –    2015-02-17 4 B $1.17 $4,680 D/D 4,000 62,500 2.73     -
   Cauwenbergh Geert President & CEO   •       •      –    2015-02-10 4 B $1.22 $2,487 D/D 2,000 58,500 2.73     -
   Bitterman Robert J Director   –       •      –    2015-01-22 4 B $1.19 $5,981 D/D 5,000 6,500 2.39     -
   Cauwenbergh Geert President & CEO   •       •      –    2015-01-20 4 B $1.03 $10,300 D/D 10,000 56,500 2.81     -
   Cauwenbergh Geert President & CEO   •       •      –    2014-12-30 4 B $1.59 $3,968 D/D 2,500 46,500 2.73     -
   Cauwenbergh Geert President & CEO   •       •      –    2014-10-13 4 B $1.68 $5,040 D/D 3,000 44,000 2.81     -
   Cauwenbergh Geert President & CEO   •       •      –    2014-09-19 4 B $2.20 $9,900 I/I 4,500 4,500 2.58     -
   Cauwenbergh Geert President & CEO   •       •      –    2014-09-16 4 B $2.08 $10,390 I/I 5,000 46,000 2.58     -
  134 Records found
  1  2  3  4  5  6   
  Page 5 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us